CAT No: CP00636
CAS No:103213-32-7
Synonyms/Alias:Fmoc-Cys(Trt)-OH;FMOC-S-trityl-L-cysteine;103213-32-7;CHEMBL396414;N-(9-Fluorenylmethoxycarbonyl)-S-trityl-L-cysteine;Na-Fmoc-Ng-trityl-L-glutamine;n-[(9h-fluoren-9-ylmethoxy)carbonyl]-s-trityl-l-cystein;Nalpha-Fmoc-S-trityl-L-cysteine;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-(triphenylmethyl)-L-cysteine;(R)-(9H-Fluoren-9-yl)methyl(1-hydroxy-3-(tritylthio)propan-2-yl)carbamate;Fmoc-S-trityl-cys;N-Fmoc-S-trityl-L-cysteine;PubChem10010;Fmoc-S-Trityl-Cys-OH;Fmoc-L-Cys(Trt)-OH;Fmoc-Cys(trt))-OH;AC1L2TFO;AC1Q5QT8;KSC176O9R;47695_ALDRICH;N|A-Fmoc-S-trityl-L-cysteine;SCHEMBL1738641;08503_FLUKA;47695_FLUKA;CTK0H6798
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.